This was fully investigated in 1849, by British physician Thomas Addison, from which it acquired the common name of Addison's anemia
About 15% of patients taking semaglutide had wound up suffering a recurrence of pancreatitis, compared with 24% in the SGLT2 inhibitor group, 23% in the DPP4 group and nearly 52% of patients not taking any drugs at all
Additionally, semaglutide increases glucose-dependent insulin secretion, suppresses glucagon, and may contribute to metabolic improvements beyond weight loss alone
Bonetti G, Herbst KL, Dhuli K, et al
For many businesses, the GLP-1 RUO market now presents a level of legal exposure that is difficult to justify
GersteinHCColhounHMDagenaisGRDiazRLakshmananMPaisPet alDulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial